Archives
-
Amikacin in CREC Resistance Assays
2026-08-18
Amikacin and BAY416651 can help researchers connect aminoglycoside exposure with resistance genotype, plasmid mobility, and bacterial protein synthesis. This guide translates recent CREC transmission findings into practical assay design and interpretation decisions.
-
Measuring Cancer Drug Responses Beyond Viability
2026-08-17
Hannah Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of cancer drug response. Its central contribution is a framework that separates proliferative arrest from cell killing and emphasizes their different magnitudes and timing, improving interpretation of in vitro pharmacology.
-
HA-LNP PTEN mRNA for Transdermal Melanoma Therapy
2026-08-17
A 2026 Journal of Controlled Release study developed hyaluronate-conjugated lipid nanoparticles containing PTEN mRNA for topical, transdermal melanoma immunotherapy. The HA-DMG formulation combined nanoparticle stabilization with CD44-directed targeting, enabling skin and tumor penetration, PTEN restoration, immunogenic cell death, tumor growth suppression, and immune activation in preclinical models.
-
DZNep: A Context-Aware Epigenetic Strategy
2026-08-16
3-Deazaneplanocin (DZNep) is more than an EZH2-associated research reagent. Its dual action through S-adenosylhomocysteine hydrolase and epigenetic remodeling creates a platform for studying apoptosis, tumor-initiating states, and tissue-specific biology. This thought-leadership article outlines how translational researchers can use DZNep with stronger mechanistic controls, heterogeneity-aware study design, and more disciplined interpretation across oncology and metabolic models.
-
Quantifying 1-methyl Adenosine by UHPLC–MS/MS
2026-08-15
The 2024 Analytical Chemistry study developed a stable isotope-diluted UHPLC–ESI-MS/MS method for sensitive, selective measurement of methylated purine ribonucleosides in cells. Its combination of ammonium bicarbonate-enhanced ionization, solid-phase cleanup, and chromatographic isomer resolution provides a practical foundation for intracellular RNA modification research and downstream biomarker studies.
-
Ionomycin calcium salt for Calcium Signaling
2026-08-14
Ionomycin calcium salt provides a practical way to raise intracellular Ca2+ for calcium imaging, secretion assays, apoptosis studies, and pathway validation. This guide connects controlled ionophore treatment with STIM1-centered prostate cancer research while emphasizing dose finding, orthogonal readouts, and troubleshooting.
-
VX-765 Workflow for Caspase-1 and Pyroptosis
2026-08-14
VX-765 enables selective interrogation of caspase-1-driven cytokine release, macrophage pyroptosis, and translational inflammation models. This practical guide connects biochemical validation with cell-based controls, assay optimization, and evidence-aware interpretation of results.
-
Spatial Proteomics Maps PD-L1–IL-6 Crosstalk in PSC
2026-08-13
Orlandi and colleagues integrate spatial proteomics with cell-cell cross-talk analysis to examine how PD-L1 and IL-6 signaling are organized at the epithelial–immune interface in human primary sclerosing cholangitis. The study’s main contribution is a spatial, tissue-level framework for interpreting coupled immune-checkpoint and inflammatory signaling while distinguishing interaction inference from proven molecular causality.
-
EGF as a Control Point in Glioblastoma Stemness
2026-08-13
A translational framework for using recombinant human EGF as a defined perturbation in 3D glioblastoma spheroid assays, connecting EGFR biology, assay design, product qualification, and the limits of stemness interpretation.
-
Proteinase K for DNA Prep and EV Assays
2026-08-12
Proteinase K combines broad protein digestion with compatibility across SDS, EDTA, and moderate heat, making it useful for genomic DNA isolation and enzyme contaminant removal. This guide also shows how to adapt protease-protection logic to Candida albicans extracellular-vesicle assays without overstating what the reference study proved.
-
Amikacin (BAY416651) in Resistance Research
2026-08-12
Amikacin (BAY416651) is more than a bacterial protein synthesis inhibitor: it is a useful probe for connecting ribosomal activity, resistance mechanisms, and tissue-level antibiotic delivery. This article translates targeted granuloma-delivery findings into practical decisions for antibiotic resistance research and assay design.
-
AZ505 SMYD2 Inhibition Workflow
2026-08-11
AZ505 combines substrate-competitive SMYD2 inhibition with a practical workflow for measuring methylation, inflammatory signaling, and fibrotic phenotypes. This guide translates renal fibrosis evidence into reproducible assay design while defining sensible extensions for epigenetic regulation research and cancer biology research.
-
Dihydroartemisinin: From Artemisia to Assay Logic
2026-08-11
Dihydroartemisinin is more than an Artemisia-derived antimalarial agent. This evidence-led guide shows how to separate chemical handling, parasite assays, mTOR studies, and inflammatory models for more defensible biotechnology research.
-
Low-Molecular-Weight Inhibitors of Complement
2026-08-10
Schubart and colleagues review how selective low-molecular-weight inhibitors of complement factors B and D can suppress dysregulated alternative-pathway amplification while retaining oral drug-like properties. The paper connects pathway biochemistry, inhibitor discovery, functional assays, and translational disease models, providing a framework for evaluating alternative complement therapeutics.
-
Protease Inhibitor Cocktail EDTA-Free for TCR Assays
2026-08-09
Preserve fragile LAG-3–TCR signaling complexes, phosphorylation-sensitive targets, and native protein interactions with an EDTA-free, broad-spectrum inhibitor formulation. This workflow-focused guide shows how to use a 100X DMSO stock in Western blotting, co-immunoprecipitation, kinase assays, and proximity-oriented immunology experiments without introducing a metal chelator.